Sonoma Pharmaceuticals (SNOA) EPS (Basic): 2010-2012
Historic EPS (Basic) for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$0.05.
- Sonoma Pharmaceuticals' EPS (Basic) rose 44.44% to -$0.05 in Q4 2012 from the same period last year, while for Dec 2012 it was -$0.18, marking a year-over-year increase of 30.77%. This contributed to the annual value of -$0.27 for FY2012, which is 10.00% up from last year.
- Latest data reveals that Sonoma Pharmaceuticals reported EPS (Basic) of -$0.05 as of Q4 2012, which was down 0.00% from -$0.05 recorded in Q3 2012.
- Sonoma Pharmaceuticals' EPS (Basic)'s 5-year high stood at -$0.02 during Q2 2012, with a 5-year trough of -$0.09 in Q2 2010.
- In the last 3 years, Sonoma Pharmaceuticals' EPS (Basic) had a median value of -$0.06 in 2011 and averaged -$0.06.
- Examining YoY changes over the last 5 years, Sonoma Pharmaceuticals' EPS (Basic) showed a top increase of 75.00% in 2012 and a maximum decrease of 66.67% in 2012.
- Over the past 3 years, Sonoma Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.08 in 2010, then fell by 12.50% to -$0.09 in 2011, then soared by 44.44% to -$0.05 in 2012.
- Its last three reported values are -$0.05 in Q4 2012, -$0.05 for Q3 2012, and -$0.02 during Q2 2012.